Most patients with chronic myeloid leukemia (CML) can live out their normal lives by taking tyrosine kinase inhibitors (TKIs). But mounting evidence also shows that roughly a third of those patients can eventually go off treatment altogether without their disease resurging.
Active surveillance is fast becoming a standard management practice for some men with prostate cancer.
Cancer treatment’s biggest failings occur in the metastatic setting, when metastatic cells escaping from the primary tumor colonize and attack critical organs
Immunotherapy made global headlines after Jimmy Carter’s successful treatment for brain cancer earlier this year. This article investigates the current state of immunotherapy for breast cancer.
Children with medulloblastoma, a rare brain cancer, face a challenging prognosis.